JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
  会員専用ページ

トップページ
学会案内
沿革
定款
役員・委員会
名誉会員・評議員
学術集会
総会学術集会
歴代総会・学術集会
支部・学術集会
学会教育研修会
国際関連学会
認定制度
リウマチ専門医
リウマチ指導医
教育施設
学会出版物
学会誌MR
NLリウマチ
リウマチ学用語集
会員手続き
本サイトについて
よくある質問
関連リンク集
サイトマップ
プライバシー

MODERN RHEUMATOLOGY Vol.14 No.6

>MR14-6

Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease
Naoki Kobayashi1, Masaaki Mori1 , Yoshinori Kobayashi1, Takako Miyamae1, Tomoyuki Imagawa1, Toshiya Okuyama2, Hiroko Kurozumi3 and Shumpei Yokota1
(1) Department of Pediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
(2) Department of Pediatrics, Yokohama Saiseikai Nambu Hospital, Yokohama, Japan
(3) Department of Pediatrics, Yokohama Minami Kyousai Hospital, Yokohama, Japan

Full Text
> Click Here (member's only)


Abstract
Proinflammatory cytokinemia and subsequent endothelial cell activation are the major pathological features of Kawasaki disease (KD), which progresses to systemic vasculitis and results in coronary artery lesions (CALs). We studied the serum levels of proinflammatory cytokines and of the soluble receptors before and after intravenous gamma-globulin (IVGG) treatment to investigate whether the anti-inflammatory effect of IVGG was due to the reduction of increased serum levels of their cytokines and soluble receptors. In the acute phase of KD, the serum levels of interleukin (IL)-2 and IL-5, as well as those of IL-6, IL-10, and interferon-, were markedly higher than those in controls. The level of tumor necrosis factor-agre was higher than that in the control, but the difference was slight and not significant. The soluble IL-6 receptor levels were lower than those of the controls. After IVGG administration, the increased levels of these cytokines and soluble receptors were abruptly down-regulated to within their normal ranges. The patients enrolled in the present study were all effectively treated with IVGG, without a steroid, and improved without any residual CALs. Overall, IVGG administration to patients with KD was found to be effective in reducing inflammatory processes and in preventing CALs, and was followed by reduction of the serum levels of the proinflammatory cytokines and their receptors.
 
Key words
Hypercytokinemia - Interleukin (IL)-6 - Intravenous gamma-globulin (IVGG) - Proinflammatory cytokine - Tumor necrosis factor (TNF)-alpha
 
一覧に戻る

Copyright Japan College of Rheumatology All rights reserved.